+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Iodine-131 Isotope Market - Global Forecast 2026-2032- Product Image
Iodine-131 Isotope Market - Global Forecast 2026-2032- Product Image
Sale

Iodine-131 Isotope Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6016558
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Iodine-131 Isotope Market is projected to reach USD 788.67 Million in 2026. It is expected to continue growing at a CAGR of 5.47%, reaching USD 1.08 Billion by 2032.

Iodine-131 Isotope: Executive Summary and Market Context

Iodine-131 is a radioactive isotope used primarily in nuclear medicine for diagnostic procedures and targeted treatment of thyroid disorders. Its clinical value depends on reliable isotope production, secure handling, specialized administration, radiation protection, and compliant radioactive-waste management. Demand conditions are shaped by thyroid-disease diagnosis, access to nuclear-medicine facilities, reactor and cyclotron capabilities, regulatory requirements, and the availability of trained personnel. Because iodine-131 has a relatively short half-life, supply coordination and distribution timing are operationally critical.

Supply Resilience and Clinical Integration Are Reshaping Iodine-131 Use

The iodine-131 landscape is being transformed by tighter integration between isotope production, radiopharmacy, hospital scheduling, and patient-specific treatment planning. Reactor maintenance, transport restrictions, precursor availability, and regulatory controls can affect continuity of care, encouraging institutions to strengthen contingency planning and coordinate procurement more closely. At the same time, advances in thyroid imaging, dosimetry, radiation-safety systems, and differentiated treatment pathways are supporting more personalized use. Environmental controls and radioactive-waste obligations are also becoming increasingly central to operating decisions.

Artificial Intelligence Improves Iodine-131 Planning, Dosimetry, and Workflow Control

Artificial intelligence can support iodine-131 services by improving image interpretation, identifying clinically relevant patterns, assisting patient selection, and helping clinicians plan individualized dosing. Predictive tools may also support scheduling, inventory coordination, quality assurance, and detection of anomalies across production and distribution workflows. However, effective adoption requires clinically validated datasets, transparent model performance, cybersecurity safeguards, human oversight, and compliance with medical-device and radiation-protection requirements. AI should augment, rather than replace, nuclear physicians, medical physicists, pharmacists, and radiochemists.

Regional Insights: Infrastructure and Regulation Shape Access Differently

North America benefits from established nuclear-medicine infrastructure, specialized clinical expertise, and mature regulatory systems, while continuity planning remains important for short-lived isotope logistics. Europe emphasizes cross-border coordination, harmonized safety practices, and resilient medical-isotope supply arrangements. Asia-Pacific combines advanced capabilities in markets such as Japan, South Korea, Australia, and China with rapidly developing access in other healthcare systems. Latin America is influenced by uneven availability of reactors, radiopharmacies, and specialist services, making referral networks and logistics important. The Middle East is expanding specialized healthcare capacity, with access shaped by investment, regulation, and imported isotope supply. Africa faces wider infrastructure and workforce constraints, although regional centers and international cooperation can improve access to diagnosis and treatment.

Group Insights: Cooperation and Policy Affect Iodine-131 Capability

ASEAN countries show varied levels of nuclear-medicine infrastructure, with regional cooperation and workforce development helping address disparities. BRICS members span substantial differences in production capability, healthcare access, regulation, and clinical capacity, creating opportunities for technical collaboration while preserving national oversight. The European Union benefits from coordinated regulatory dialogue and cross-border healthcare links, although implementation remains subject to national systems. G7 members generally possess advanced clinical and research infrastructure, with resilience, safety, and workforce sustainability remaining priorities. GCC states are strengthening specialized healthcare capacity and may rely on coordinated procurement, imported isotopes, and international expertise. NATO members vary widely, but shared emphasis on emergency preparedness, secure logistics, and critical-infrastructure resilience can support continuity of medical-isotope services.

Country Insights: Diverse Production, Access, and Clinical Priorities

Australia contributes through advanced nuclear science and regional healthcare links, while Brazil and Mexico continue to depend on the development and coordination of specialized nuclear-medicine services. Canada and the United States have sophisticated clinical and regulatory ecosystems, with supply continuity and distributed access remaining important. China, India, Japan, and South Korea combine substantial technical capabilities with large or specialized healthcare systems, while workforce and regional-access considerations persist. France, Germany, Italy, Spain, and the United Kingdom operate within strong European nuclear-medicine and radiation-safety frameworks, with procurement coordination and service capacity influencing access. Russia maintains relevant nuclear and medical-technology capabilities, while regulatory, logistical, and international operating conditions affect collaboration and supply pathways.

Industry Priorities: Build Resilience, Validate AI, and Strengthen Clinical Delivery

Industry leaders should diversify qualified supply routes where permitted, establish contingency plans for reactor outages and transport disruption, and align production schedules closely with hospital treatment calendars. Investment should prioritize radiopharmacy quality systems, radiation protection, secure waste handling, cold-chain and time-sensitive logistics controls, and training for nuclear-medicine professionals. Organizations introducing AI should begin with narrowly defined, clinically meaningful use cases and require independent validation, auditability, cybersecurity, and physician oversight. Partnerships with hospitals, regulators, academic centers, and international bodies can improve protocol consistency, workforce development, and equitable patient access.

Research Methodology: Evidence-Led Assessment of Iodine-131 Ecosystems

This executive summary uses the supplied market scope and evaluates iodine-131 through established clinical, technological, regulatory, operational, and geographic lenses. The assessment considers documented applications in thyroid medicine, isotope-production and distribution requirements, nuclear-medicine infrastructure, radiation-safety obligations, workforce needs, and the role of artificial intelligence in care and operations. Regional, group, and country observations are comparative and qualitative. No market estimates, market shares, forecasts, or company-specific claims are used; conclusions should be validated against current national regulations, facility capabilities, procurement conditions, and clinical guidelines.

Conclusion: Reliable Access Depends on Integrated, Safety-First Execution

Iodine-131 remains an important tool in thyroid-focused nuclear medicine, but its effectiveness depends on more than isotope availability. Resilient production and logistics, capable clinical teams, robust regulation, individualized dosimetry, and responsible technology adoption must operate together. Regional and country conditions differ substantially, so leaders should pair global quality and safety principles with locally appropriate delivery models. Organizations that strengthen continuity planning, evidence-based clinical integration, and workforce capability will be better positioned to support safe and dependable iodine-131 care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Iodine-131 Isotope Market, by Product Type
7.1. Introduction
7.2. Capsule
7.3. Injectable
7.3.1. Prefilled Syringe
7.3.2. Vial
7.4. Liquid Solution
8. Iodine-131 Isotope Market, by Application
8.1. Introduction
8.2. Cancer Therapy
8.2.1. Combination Therapy
8.2.2. Targeted Therapy
8.3. Medical Imaging
8.4. Thyroid Treatment
9. Iodine-131 Isotope Market, by End Use
9.1. Introduction
9.2. Diagnostic Centers
9.3. Hospitals
9.4. Research Institutes
10. Iodine-131 Isotope Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributors
11. Iodine-131 Isotope Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Iodine-131 Isotope Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Iodine-131 Isotope Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Advanced Accelerator Applications S.A.
15.2. China Isotope & Radiation Corporation
15.3. Curium Pharma SAS
15.4. Eckert & Ziegler Radiopharma GmbH
15.5. Institute for Radioelements SCRL
15.6. Jubilant Pharma Limited
15.7. Lantheus Holdings, Inc.
15.8. Mallinckrodt plc
15.9. Nordion Inc.
15.10. NorthStar Medical Radioisotopes LLC
15.11. NorthStar Medical Radioisotopes LLC
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Iodine-131 Isotope Market, Years Considered for the Study
FIGURE 2. Global Iodine-131 Isotope Market, Research Design
FIGURE 3. Global Iodine-131 Isotope Market, Research Framework
FIGURE 4. Global Iodine-131 Isotope Market, Data Triangulation
FIGURE 5. Global Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Iodine-131 Isotope Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Iodine-131 Isotope Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Iodine-131 Isotope Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Iodine-131 Isotope Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Iodine-131 Isotope Market Size, by End Use, 2025 vs 2032 (%)
FIGURE 11. Global Iodine-131 Isotope Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Iodine-131 Isotope Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Iodine-131 Isotope Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Iodine-131 Isotope Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Iodine-131 Isotope Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Iodine-131 Isotope Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Iodine-131 Isotope Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Iodine-131 Isotope Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Iodine-131 Isotope Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Iodine-131 Isotope Market Segmentation & Coverage
TABLE 2. Global Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 3. Global Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Liquid Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Liquid Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Liquid Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 20. Global Cancer Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cancer Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cancer Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Combination Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Combination Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Combination Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Targeted Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Targeted Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Targeted Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Medical Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Medical Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Medical Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Thyroid Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Thyroid Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Thyroid Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 36. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 46. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Iodine-131 Isotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Iodine-131 Isotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 60. North America Iodine-131 Isotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. North America Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. North America Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 63. North America Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. North America Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 65. North America Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 66. North America Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 67. Latin America Iodine-131 Isotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Latin America Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 69. Latin America Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 70. Latin America Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 71. Latin America Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 72. Latin America Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 73. Latin America Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 74. Europe Iodine-131 Isotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Europe Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. Europe Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 77. Europe Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Europe Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 79. Europe Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 80. Europe Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 81. Middle East Iodine-131 Isotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Middle East Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. Middle East Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 84. Middle East Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. Middle East Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 86. Middle East Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 87. Middle East Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. Africa Iodine-131 Isotope Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Africa Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Africa Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 91. Africa Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Africa Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 93. Africa Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 94. Africa Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. Global Iodine-131 Isotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. ASEAN Iodine-131 Isotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. ASEAN Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 98. ASEAN Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 99. ASEAN Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. ASEAN Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 101. ASEAN Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 102. ASEAN Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. GCC Iodine-131 Isotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. GCC Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 105. GCC Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 106. GCC Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. GCC Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 108. GCC Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 109. GCC Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. European Union Iodine-131 Isotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. European Union Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. European Union Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 113. European Union Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. European Union Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 115. European Union Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 116. European Union Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 117. BRICS Iodine-131 Isotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. BRICS Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 119. BRICS Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 120. BRICS Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. BRICS Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 122. BRICS Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 123. BRICS Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. G7 Iodine-131 Isotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. G7 Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. G7 Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 127. G7 Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. G7 Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 129. G7 Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 130. G7 Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. NATO Iodine-131 Isotope Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. NATO Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. NATO Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 134. NATO Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. NATO Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 136. NATO Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 137. NATO Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 138. Global Iodine-131 Isotope Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. United States Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 140. United States Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. United States Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 142. United States Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. United States Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 144. United States Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 145. United States Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Canada Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 147. Canada Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. Canada Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 149. Canada Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Canada Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 151. Canada Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 152. Canada Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. Mexico Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 154. Mexico Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Mexico Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 156. Mexico Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Mexico Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 158. Mexico Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 159. Mexico Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. Brazil Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 161. Brazil Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. Brazil Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 163. Brazil Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. Brazil Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 165. Brazil Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 166. Brazil Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. United Kingdom Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 168. United Kingdom Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 169. United Kingdom Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 170. United Kingdom Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. United Kingdom Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 172. United Kingdom Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 173. United Kingdom Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. Germany Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 175. Germany Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 176. Germany Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 177. Germany Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Germany Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 179. Germany Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 180. Germany Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. France Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 182. France Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. France Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 184. France Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. France Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 186. France Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 187. France Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Russia Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 189. Russia Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. Russia Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 191. Russia Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Russia Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 193. Russia Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 194. Russia Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 195. Italy Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 196. Italy Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. Italy Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 198. Italy Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Italy Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 200. Italy Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 201. Italy Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Spain Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 203. Spain Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. Spain Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 205. Spain Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Spain Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 207. Spain Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 208. Spain Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. China Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 210. China Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. China Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 212. China Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. China Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 214. China Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 215. China Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. India Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 217. India Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. India Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 219. India Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. India Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 221. India Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 222. India Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. Japan Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 224. Japan Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. Japan Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 226. Japan Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Japan Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 228. Japan Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 229. Japan Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Australia Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 231. Australia Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Australia Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 233. Australia Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Australia Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 235. Australia Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 236. Australia Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. South Korea Iodine-131 Isotope Market Size, 2017-2032 (USD Million)
TABLE 238. South Korea Iodine-131 Isotope Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. South Korea Iodine-131 Isotope Market Size, by Injectable, 2017-2032 (USD Million)
TABLE 240. South Korea Iodine-131 Isotope Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. South Korea Iodine-131 Isotope Market Size, by Cancer Therapy, 2017-2032 (USD Million)
TABLE 242. South Korea Iodine-131 Isotope Market Size, by End Use, 2017-2032 (USD Million)
TABLE 243. South Korea Iodine-131 Isotope Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Global Iodine-131 Isotope Market Share, by Key Player, 2025
TABLE 245. Global Iodine-131 Isotope Market, Key Experts

Companies Mentioned

  • Advanced Accelerator Applications S.A.
  • China Isotope & Radiation Corporation
  • Curium Pharma SAS
  • Eckert & Ziegler Radiopharma GmbH
  • Institute for Radioelements SCRL
  • Jubilant Pharma Limited
  • Lantheus Holdings, Inc.
  • Mallinckrodt plc
  • Nordion Inc.
  • NorthStar Medical Radioisotopes LLC
  • NorthStar Medical Radioisotopes LLC

Related Topics

Related Reports

Medical Radioactive Iodine I-131 Market - Global Forecast 2026-2032 - Product Image

Medical Radioactive Iodine I-131 Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Iodine Radioisotope Market - Global Forecast 2026-2032 - Product Image

Iodine Radioisotope Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Iodine Market Report by Source, Form, Application, and Region 2026-2034 - Product Image

Iodine Market Report by Source, Form, Application, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From
Iodine Market Report 2026 - Product Image

Iodine Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Iodine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Iodine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.